Can the European Biotech Act Make Europe a Global Biotech Leader?

European Biotech Act

Sandrine Piret-Gerard: Closing a Meaningful 4-Year Chapter at Gilead Sciences

Sandrine Piret-Gerard

Naveen Pemmaraju: Bringing More Global Awareness and a New International Collaboration for BPDCN

Naveen Pemmaraju

Become a Volunteer and Help Build the Global Directory of Oncologists

Volunteer

Joseph Grossman: Clinical Results of Botensilimab Plus Balstilimab in Treatment-Refractory Ovarian Cancer

Joseph Grossman

Oncology News, Insights, Stories by OncoDaily

100 Most Influential People
OncoDaily 100

The 100 Most Influential People in Oncology in 2025 (Full List)

AstraZeneca Pan‑KRAS Inhibitor
OncoIndustry

Jacobio Pharma and AstraZeneca Strike $2 B Deal for Pan‑KRAS Inhibitor

Jemma Arakelyan
Voices

Jemma Arakelyan: Oncology Is Not Chosen for Work-Life Balance - It’s Chosen for Purpose

Botensilimab + Balstilimab in Platinum-Resistant Ovarian Cancer

Douglas Flora: Stop Preparing For AI, Start Using It - Your 12-Week Resolution for 2026

AACR Launches MONARCA Grants for Latin American Cancer Scientists

Ben Sasse on Being "On the Clock" After a Pancreatic Cancer Diagnosis

John F. Crowley: A Legacy For Rare Diseases

PLANeT Trial: Low-Dose Pembrolizumab Plus Neoadjuvant Chemotherapy in Localized TNBC

The International Incidence of Childhood Cancer, Volume III is Available - IARC/WHO

OncoThon 2026
OncoDaily 100
Act 4 Children
Grand Rounds GI
OncoDaily Party: Berlin 2025
awards
awards
awards
awards
awards
awards

Voices
Mark Cuban

Mark Cuban: This is Why We Started Mark Cuban Cost Plus Drug Company

Cathy Eng: Wishing Peace, Joy, and Good Health This Holiday Season

Amer Zeidan: And Then Came the 1st Successful Targeting in Human Disease with Imetelstat...

Ginny Mason: Addressing Financial Toxicity in Cancer Care

Sacituzumab Govitecan/ Pembrolizumab vs Salvage Chemotherapy in Urothelial Cancer - ECOG-ACRIN Cancer Research Group

Neil Vasan: 4 FDA-Approved Drugs in Breast Cancer in 2025

Antonio Giordano: Proud of the Incredible Team at Dana-Farber’s CCTI

FDA Approvals
FDA Approves RYBREVANT FASPRO as the First Subcutaneous Amivantamab Option for EGFR-Mutated NSCLC

FDA Approves RYBREVANT FASPRO as the First Subcutaneous Amivantamab Option for EGFR-Mutated NSCLC

FDA Approved Rucaparib for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

FDA Approves Fam-Trastuzumab Deruxtecan-nxki With Pertuzumab for First-Line Treatment of HER2-Positive Metastatic Breast Cancer

FDA Approves Niraparib Plus Abiraterone for BRCA2-Mutated Metastatic Castration-Sensitive Prostate Cancer

New Hope for NUT Carcinoma: FDA Grants Orphan Drug Status to ZEN-3694

FDA approved Durvalumab plus FLOT for resectable gastric or GEJ adenocarcinoma

FDA Approves Pembrolizumab + Enfortumab Vedotin-ejfv for Cisplatin-Ineligible Muscle-Invasive Bladder Cancer

OncoDaily 100
100 Most Influential People

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024

Top 100 Xfluencers in Pediatric Hematology/Oncology: Key Opinion Leaders to follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

EASL Liver Cancer Summit 2026

European Association for the Study of the Liver (EASL)

22 Jan
EASL Liver Cancer Summit

29th British Oncology Pharmacy Association (BOPA) Annual Conference

British Oncology Pharmacy Association (BOPA)

02 Oct
British Oncology Pharmacy Association

The UK Interdisciplinary Breast Cancer Symposium (UKIBCS 2026)

Breast Cancer Now

19 Jan
UKIBCS

ALIGN 2026: Advancing Learning and Innovation in Goal Concordant Care

MD Anderson Cancer Center

29 Apr
ALIGN 2026

3rd International CAM Conference (CAMCON 2026)

European Association for Cancer Research

30 Jun
CAM Conference

Immune-oncology
10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

Positive Topline Results from Phase 3 RINGSIDE Trial: Varegacestat Significantly Improves Outcomes in Desmoid Tumors

How Do Pharmacists Protect the Safety and Effectiveness of Immunotherapy?

10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

The "Off-the-Shelf" Revolution: How iNKT Cell Therapy agenT-797 is Reprogramming the Fight Against Solid Tumors

10 Posts Not to Miss from ESMO

OncoDaily TV
Global Health Dialogues

Global Health Dialogues with Princess Dina Mired: Prof. Kofi Mensah Nyarko

Global Health Dialogues with Princess Dina Mired | Episode 3: HE Dr. Ahmed Mohammed Obaid Al Saidi

Global Health Dialogues with Princess Dina Mired | Episode 3: HE Dr. Ahmed Mohammed Obaid Al Saidi

Mina S. Sedrak

Mina S. Sedrak: Shaping the Future of Cancer and Aging Research, Redefining Survivorship

Yuman Fong

Yuman Fong: Exclusive Interview on Innovation, Mentorship and the Future of Surgical Oncology

Immunotherapy in Nigeria

Opening New Frontiers for Cancer Care in Africa: Bringing Colorectal Cancer Immunotherapy in Nigeria

The Asher Series Survivorship and Beyond Presented by OncoDaily LA

The Asher Series Survivorship and Beyond Presented by OncoDaily LA

Gregory Kalemkerian

60 questions about SCLC with Dr. Gregory Kalemkerian Part 1

Mohamed Osman

ONCOFFEE: Mohamed Osman – Building a Research Career from Egypt to New York

Susan G. Komen

How Is Susan G. Komen Changing the Future of Breast Cancer Care?

Sarah J. Winston

How Sara J. Winston Transformed Her Multiple Sclerosis Diagnosis Into a Story of Art and Healing

Beyond the Cancer Diagnosis

Beyond the Cancer Diagnosis: Interview with Michelle Peate, Hosted by Adrian Pogacian

Empowering Oncologists Yüksel Ürün

Empowering Oncologists: How my professional enthusiasm made me a global leader in Oncology?

Not To Miss
OncoDaily Weekly

Oncology This Week: OncoDaily Weekly Dec 15-21

Oncology This Week: OncoDaily Weekly Dec 8–14, 2025

25 Posts Not to Miss from SABCS 2025

20 Posts Not to Miss from SABCS 2025, Part 2

25 Posts Not to Miss from ASH 2025

15 Posts Not to Miss from SABCS 2025, Part 1

20 Posts Not to Miss from ASH 2025, Part 2

OncoGrants
Alex’s Lemonade Stand Foundation Pediatric Oncology Student Training (POST) Program

Alex’s Lemonade Stand Foundation Pediatric Oncology Student Training (POST) Program

CRI Immuno-Informatics Postdoctoral Fellowship

CRI Immuno-Informatics Postdoctoral Fellowship

ASTRO Medical Student Fellowship

ASTRO Medical Student Fellowship

ASCO Clinical Oncology Research Experience (CORE) for Medical Students

ASCO Clinical Oncology Research Experience (CORE) for Medical Students

Conquer Cancer – Career Development Award in Triple-Negative Breast Cancer

Conquer Cancer – Career Development Award in Triple-Negative Breast Cancer

Rising Tide Foundation – Clinical Cancer Research Grants

Rising Tide Foundation – Clinical Cancer Research Grants

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Colorectal Cancer

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

Cervical Cancer: Symptoms, Causes, Stages, Diagnosis and Treatment

Craniopharyngioma: Symptoms, Diagnosis, Treatment, and 2025 Breakthroughs in Targeted Therapy and Precision Care

Malignant Schwannoma: Comprehensive Guide to Causes, Symptoms, Diagnosis, Treatment, Prognosis, and 2025 Advances in Schwannoma Care

Meningioma: Types, Symptoms, Diagnosis, Treatment, Malignancy Risk, and 2025 Breakthroughs

CancerWorld
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

Oncologists
Douglas Flora

Douglas Flora

Edgewood, USA
LIdia Schapira

Lidia Schapira

Stanford, USA
Allison F. O'Neill

Allison F. O’Neill

Boston, USA
Chandler Park

Chandler Park

Louisville, USA
Gabriele Todisco

Gabriele Todisco

Milan, Italy
Michael Jefford

Michael Jefford

Melbourne, Australia
Tezer Kutluk

M. Tezer Kutluk

Ankara, Türkiye
Florian Lordick

Florian Lordick

Leipzig, Germany

Oncology Drugs
Vepdegestrant (ARV-471): What Patients With Advanced Breast Cancer Need to Know

Vepdegestrant (ARV-471): What Patients With Advanced Breast Cancer Need to Know

Vepdegestrant (ARV-471): Redefining Estrogen Receptor Targeting in Advanced Breast Cancer

Imjudo (Tremelimumab) Guide for 2025: What patients need to know?

Tremelimumab (Imjudo) Updates 2025: Uses in Cancer, Dosage, Side Effects, Expectations, and More

Darovasertib for Uveal Melanoma: What Patients Need to Know

Darovasertib: A Deep Dive Into a First-in-Class PKC Inhibitor Reshaping the Treatment Landscape of Metastatic Uveal Melanoma

Amivantamab for Lung Cancer: What Patients Need to Know

OncoDaily Magazine
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

New Paper Alert
ctDNA CRC

NEW GI Paper Alert: Clinical Performance of Tumor-Informed vs Tumor-Agnostic ctDNA for Colorectal Cancer Recurrence

TROPION-Breast01

Dato-DXd vs Chemotherapy: Final Overall Survival Results From TROPION-Breast01

CAPItello-290 trial

New Paper Alert: CAPItello-290 Results of Capivasertib Plus Paclitaxel in mTNBC

ESMO-ESTRO Consesnus Radiotherapy

ESMO–ESTRO Consensus on the Safety of Combining Radiotherapy With CDK4/6, HER2, PARP, and mTOR Inhibitors

New GI Paper Alert for colorectal cancer

New GI Paper Alert: Survival outcomes of ERBB2-amplified metastatic colorectal cancer treated with first-line chemotherapy

CHRYSALIS-2 Trial

Treatment Outcomes With Amivantamab–Lazertinib in EGFR Mutant NSCLC: CHRYSALIS-2 Trial

OncoDaily Medical Journal

Precision Oncology

10.69690/ODMJ-019-0829-4588

Harnessing Real-World Evidence to Support Precision Oncology
Opinion

Pediatric Oncology

10.69690/ODMJ-001-0829-4568

Identifying the Factors Contributing to Treatment Abandonment in Childhood Cancers at a Tertiary Care Hospital in Pakistan
Original Research

Global Oncology

10.69690/ODMJ-001-0811-4701

The Role of National and Regional Cancer Registries in Shaping Cancer Care Policies
Original Research

Pediatric Oncology

10.69690/ODMJ-001-0809-4599

Survival Outcomes of Wilms' Tumor in Pediatric Patients Treated at KFMC: A Retrospective Study of 15 years from 2007-2022
Original Research

GI Oncology

10.69690/ODMJ-018-0425-4320

Colorectal Cancer in Latin America: Quick Comment
Commentaries

GI Oncology

10.69690/ODMJ-002-0701-4309

Current Perspective of Gastro-intestinal Cancer in Guatemala
Review/Meta-Analysis

Pediatric Oncology

10.69690/ODMJ-003-0520-4233

In the Crossfire: A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group
Editorial

Pediatric Oncology

10.69690/ODMJ-018-0425-4062

CD19+ CAR-T Therapy for Relapsed or Refractory B-ALL and Burkitt Lymphoma in Children and Young Adults in the Republic of Belarus
Abstracts